Volume 2, Number 2—April 1996
Emergence of Bartonella quintana Infection among Homeless Persons
Bartonella quintana has episodically emerged as a cause of infection among distinct and diverse populations during the 20th century. The organism was first identified as an important human pathogen during World War I when it caused epidemics of louse-borne trench fever that affected an estimated 1 million troops in Europe (1, 2). Trench fever was characterized by fever, rash, bone pain, and splenomegaly and ranged in severity from a mild flulike illness to a more severe, relapsing disease. B. quintana infections were rarely recognized from the end of World War II until the 1980s when the organism reemerged as an opportunistic pathogen among HIV-infected persons. In this population, B. quintana has been identified as a cause of bacillary angiomatosis, endocarditis, and bacteremia (3-5) and has been isolated from AIDS patients in France (6) and the United States (3-5).
In the 1990s, B. quintana has emerged among homeless persons in North America and Europe. In 1993, the organism was isolated from the blood specimens of 10 patients at a single hospital in Seattle, Washington, within a 6-month period (7). These patients had illnesses characterized by fever and persistent bacteremia. Endocarditis developed in two patients, one of whom required a heart valve replacement. All 10 patients had chronic alcoholism, eight were homeless, and the six who were tested for HIV infection were HIV-negative. These six were the first cases of invasive B. quintana infection among HIV-negative persons reported in the United States. Results of a case-control study indicated that the patients with Bartonella bacteremia were more likely than controls (other hospitalized patients from whom blood specimens were obtained at approximately the same time) to be homeless (p = 0.001), to have a history of alcohol abuse (p = 0.001), and to be nonwhite (p = 0.007). The isolates from the 10 patients were identical by polymerase chain reaction restriction-fragment-length polymorphism testing, which further suggests that the cases were epidemiologically linked. Patients’ characteristics were obtained by retrospective medical record review, and at the time they sought treatment, three patients reported a recent cat scratch, five had scabies, and one had lice. More complete information, however, on patients’ past exposures to animals and ectoparasites was not available.
In 1995, Drancourt and co-workers reported three cases of B. quintana endocarditis among HIV-negative, homeless, alcoholic men in France (8). One of the patients had reported contact with a dog, and one had reported contact with dogs and cats; however, a current or past history of infection with lice or scabies was not documented for any of the patients. In 1995, Stein and Raoult also reported serologic evidence of B. quintana infection in an HIV-negative, homeless man from Marseilles, who had a relapsing febrile illness and a history of louse infestation (9).
As a follow-up to the 1993 B. quintana outbreak in Seattle in 1994, we conducted a seroprevalence study of anti-Bartonella antibodies among patients at a community clinic in the “skid row” section of Seattle, which serves a primarily homeless and indigent population (10). The median age of the 192 patients included in the study was 45 years, 156 (81%) of the 192 were male, and 126 (66%) were classified as homeless. B. quintana IgG titers >= 64 were detected by an indirect fluorescence antibody assay (11) in 39 (20%) of the 192 clinic patients. In contrast, only 4 (2%) of 199 banked blood specimens from an age-matched and sex-matched comparison group of Seattle volunteer blood donors had titers >=64 (p < 0.001). Among clinic patients, seropositivity (titer >=64) was associated by univariate analysis with older age, homelessness (relative risk [RR] 2.0; 95% confidence interval [CI] 1.0-4.1), alcohol abuse (RR, 2.5; 95% CI 1.4-4.2), smoking (RR, 2.0; 95% CI 1.2 -3.4), and injection drug use (RR, 2.5; 95% CI 1.3-4.8). By multivariate analysis, only alcohol abuse remained independently associated with seropositivity (odds ratio 3.3; 95% CI 1.6-6.9), and of 39 seropositive patients, 21 (54%) had a history of chronic alcoholism. Reliable data on past exposure to animals or ectoparasites were also not available for patients in this study.
The study was limited by the well-described cross-reactivity of the assay between Bartonella species (12, 13), and most (62%) clinic patients with B. quintana >= 64 also had titers >= 64 to B. henselae. It is, therefore, possible that some of the seropositive patients may have been exposed to Bartonella species other than B. quintana. These findings do, however, show that a surprisingly high proportion of clinic patients without a history of documented Bartonella infection had detectable anti-Bartonella antibodies and may have been exposed to B. quintana.
Multiple factors, including those related to disease transmission, host susceptibility, and ability to detect the organism, have likely contributed to the emergence of B. quintana infection among the homeless. Transmission of B. quintana from human to human by the body louse, Pediculus humanus, has been experimentally documented (1) and is believed to have been the predominant mode of transmission of epidemic trench fever in World Wars I and II. Lice reside primarily in the seams of clothing and are easily killed by immersion in water 50°C or warmer (14), which explains the propensity for louse-borne infections among displaced persons or wartime troops. Although these reports of B. quintana infection among homeless persons lack sufficient information to conclusively determine the disease vector, louse-borne infection remains a plausible hypothesis. Lice, however, have not been associated with bacillary angiomatosis among AIDS patients, although exposure to cats (and, therefore, possibly to fleas) has been associated with bacillary angiomatosis and bacillary peliosis caused by Bartonella species (15) and with cat-scratch disease caused by B. henselae (16). Thus, it is possible that B. quintana infection is spread among homeless persons by as yet unidentified vectors or reservoirs.
Homeless persons are also at risk for non-vectorborne infectious diseases. An increased risk for tuberculosis in this population is well documented (17, 18), and outbreaks of meningococcal disease (19, 20), pneumococcal disease (21), and diphtheria (22, 23) have been reported. It is likely that factors such as crowding, altered immunity due to alcoholism or other co-existing health problems, and inadequate or infrequent access to medical care affect the transmission and spread of infectious diseases among the homeless. Previous studies have shown that the clinical response to a standard inoculum of B. quintana varies substantially in experimental study patients (1); this variation indicates that host factors are likely important determinants of the risk for clinical infection following exposure to the organism.
Although cases of B. quintana bacteremia among homeless persons have thus far been reported only from France and Seattle, Washington, the problem is probably not confined to these locations. B. quintana is a fastidious and slow-growing bacterium that generally requires special culturing techniques for isolation (3-5, 24), and many clinical laboratories do not routinely use blood culturing methods that are sensitive for isolating this organism. Moreover, B. quintana infection can result in a broad range of often nonspecific clinical manifestations (1, 3-5); therefore, case-patients evaluated for suspected bacteremia may represent only a small proportion of infected persons, as suggested by the results of the Seattle seroprevalence survey. To better define the geographic distribution and prevalence of B. quintana infection among homeless populations, a heightened awareness for this infection on the part of clinicians and the use of appropriate culture techniques by microbiology laboratories serving this population are needed. In addition, more specific serologic tests would aid in the diagnosis and assessment of the epidemiologic characteristics of B. quintana infections.
The optimal treatment regimen for HIV-negative patients with suspected or confirmed B. quintana infection has not been established. Minimal published data exist regarding antimicrobial therapy for this infection, and in vitro susceptibility testing has provenunreliable (25). Nonetheless, on the basis of limited data, we believe it is reasonable to treat immunocompetent patients who have uncomplicated B. quintana bacteremia with at least 14 days of oral therapy with erythromycin, azithromycin, doxycycline, or tetracycline. In the 1993 Seattle outbreak, most patients had a satisfactory response to treatment with a beta-lactam agent followed by either erythromycin or azithromycin for 14 days (7). Although the number of patients identified with B. quintana endocarditis is small, most of these patients have required cardiac valve replacement despite intravenous antimicrobial therapy (5, 8, 26). Therefore, we recommend that patients with B. quintana endocarditis receive a more prolonged course of at least 4 to 6 months of antimicrobial therapy and cardiac valve replacement if needed. Further study is needed to determine the role of bactericidal agents, such as third generation cephalosporins or quinolones, as monotherapy or in combination with a bacteriostatic agent for treating invasive B. quintana infections.
Many aspects of the acquisition and pathogenesis of B. quintana infections, and specifically B. quintana infections among the homeless, are not well defined. Changes in the organism itself that have led to increased virulence may in part account for its reemergence; however, microbiologic data that can support or refute this hypothesis are lacking (27). The absence of recently identified cases in Seattle and in other areas with laboratories that use culture techniques appropriate for isolating Bartonella species suggests an episodic pattern of disease, with few or no cases occurring during interepidemic periods. It seems clear, however, that this most recent emergence of an old disease is related, at least in part, to societal factors that have contributed to urban decay and the existence of large homeless populations in our cities. As with other emerging infectious diseases, further efforts to identify, evaluate, and control B. quintana infections among homeless persons are challenges that will require the coordinated effort of clinicians, microbiologists, and public health officials.
- Vinson JW, Varela G, Molina-Pasquel C. Trench fever. III. Induction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar. Am J Trop Med Hyg. 1969;18:713–22.
- Slater LN, Welch DF. Rochalimaea species (recently renamed Bartonella). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone, 1995:1741-7.
- Welch DF, Pickett DA, Slater LN, Steigerwalt AG, Brenner DJ. Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol. 1992;30:275–80.
- Koehler JE, Quinn FD, Berger TG, LeBoit PE, Tappero JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med. 1992;327:1625–31.
- Spach DH, Callis KP, Paauw DS, Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol. 1993;31:692–4.
- Maurin M, Roux V, Stein A, Ferrier F, Viraben R, Raoult D. Isolation and characterization by immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, western blot, restriction fragment length polymorphism-PCR, 16S rRNAgene sequencing, and pulsed-field gel electrophoresis of Rochalimaea quintana from a patient with bacillary angiomatosis. J Clin Microbiol. 1994;32:1166–71.
- Spach DH, Kanter AS, Dougherty MJ, Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med. 1995;332:424–8.
- Drancourt M, Mainardi JL, Brouqui P, Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med. 1995;332:419–23.
- Stein A, Raoult D. Return of trench fever [letter]. Lancet. 1995;345:450–1.
- Jackson LA, Spach DH, Kippen DA, Sugg NK, Regnery RL, Sayers MH, Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis. 1996;173:1023–6.
- Regnery RL, Olson JG, Perkins BA, Bibb W. Serologic response to “Rochalimaea henselae” antigen in suspected cat scratch disease. Lancet. 1992;339:1443–5.
- Waldvogel K, Regnery RL, Anderson BA, Caduff R, Caduff J, Nadal D. Disseminated cat-scratch disease: detection of Rochalimaea henselae in affected tissues. Eur J Pediatr. 1994;153:23–7.
- Dalton MJ, Robinson LE, Cooper J, Regnery RL, Olson JG, Childs JE. Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med. 1995;155:1670–6.
- Elgart ML. Pediculosis. Dermatol Clin. 1990;8:219–28.
- Tappero JW, Mohle-Boetani J, Koehler JE, The epidemiology of bacillary angiomatosis and bacillary peliosis. JAMA. 1993;269:770–5.
- Zangwill KM, Hamilton DH, Perkins BA, Cat scratch disease in Connecticut: epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med. 1993;329:8–13.
- Barnes PF, El-Hajj H, Preston-Martin S, Transmission of tuberculosis among the urban homeless. JAMA. 1996;275:305–7.
- Nardell E, McInnis B, Thomas B, Weidhaus S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570–5.
- Filice GA, Englender SJ, Jacobson JA, Group A meningococcal disease in skid rows: epidemiology and implications for control. Am J Public Health. 1984;74:253–4.
- Counts GW, Gregory DF, Spearman JG, Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program. Rev Infect Dis. 1984;6:640–8.
- DeMaria A Jr, Browne K, Berk SL, An outbreak of type I pneumococcal pneumonia in a men’s shelter. JAMA. 1980;244:1446–9.
- Pedersen AHB, Spearman J, Tronca E, Diphtheria on skid road, Seattle, Washington, 1972-75. Public Health Rep. 1977;92:336–42.
- Heath CW Jr, Zusman J. An outbreak of diphtheria among skid row men. N Engl J Med. 1962;267:809–12.
- Larson AM, Dougherty MJ, Nowowiejski DJ, Welch DF, Matar GM, Swaminathan B, Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol. 1994;32:1492–6.
- Myers WF, Grossman DM, Wisseman CL. Antibiotic susceptibility patterns in Rochalimaea quintana, the agent of trench fever. Antimicrob Agents Chemother. 1984;25:690–3.
- Spach DH, Kanter AS, Daniels NA, Bartonella (Rochalimaea) quintana species as a cause of culture-negative endocarditis. Clin Infect Dis. 1995;20:1044–7.
- Relman DA. Has trench fever returned? N Engl J Med. 1995;332:463–4.
Suggested citation: Jackson LA and Spach DH. Emergence of Bartonella quintana Infection among Homeless Persons. Emerg Infect Dis [serial on the Internet]. 1996, Jun [date cited]. Available from http://wwwnc.cdc.gov/eid/article/2/2/96-0212
- Page created: December 20, 2010
- Page last updated: December 20, 2010
- Page last reviewed: December 20, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)